Intrinsiqq
Fractyl Health Inc. logo

Fractyl Health Inc. Insider Trading

GUTS

Compare
Last 12 months

Insiders bought 187K on the open market and sold nothing.

Net open-market
+187K
7 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
5 / 0
executives and directors
Last open-market buy
Sep 2026
Sep 14, 2026

Get an email when GUTS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 14
    William Bradley
    Director · bought 64,516 at $0.62
    40K
    76% of stake
  • Jun 12
    Ajay Royan
    Director · bought 23,000 at $0.85
    20K
    1.8% of stake
  • Jun 10
    William Bradley
    Director · bought 68,493 at $0.73
    50K
    425% of stake
  • Jun 10
    Ian Sheffield
    Director · bought 35,000 at $0.73
    26K
    New position
  • Jun 10
    Harith Rajagopalan
    Chief Executive Officer · bought 25,000 at $0.73
    18K
    2.2% of stake
  • Jun 8
    Weber Lara Smith
    Chief Financial Officer · bought 20,000 at $0.69
    14K
    New position
  • Dec 4, 2025
    Harith Rajagopalan
    Chief Executive Officer · bought 10,416 at $1.92
    20K
    1.0% of stake
  • Mar 14, 2025
    Ajay Royan
    Director · bought 17,901 at $1.28
    23K
    1.4% of stake
  • Mar 14, 2025
    Kelly Ann Barnes
    Director · bought 31,000 at $1.30
    40K
    New position
  • Mar 13, 2025
    Amy W Schulman
    Director · bought 8,550 at $1.17
    10K
    New position
  • Mar 13, 2025
    William Bradley
    Director · bought 16,129 at $1.26
    20K
    New position
  • Mar 13, 2025
    Samuel Conaway
    Director · bought 8,550 at $1.17
    10K
    New position
  • Jan 30, 2025 – Jan 31, 202510b5-1 plan
    Harith Rajagopalan
    Chief Executive Officer · sold 111,920 at avg $1.84
    206K
    9.3% of stake
  • Jan 30, 2025 – Jan 31, 202510b5-1 plan
    Jay David Caplan
    President, Chief Product Off. · sold 43,818 at avg $1.88
    82K
    6.5% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch GUTS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with GUTS

CompareIntrinsic value
PAVMPAVmed Inc.
$1.14-5.42%35
MBOTMicrobot Medical Inc.
$0.68-8.11%25
RDGLVivos Inc.
$0.04-2.68%40
SIGYSigyn Therapeutics Inc.
$0.03+0.00%30
ODYYOdyssey Group International Inc.
$0.01-7.14%10
NVNOEnVVeno Medical Corporation
$5.25-5.75%10
GCTKGlucotrack Inc.
$0.18-1.98%25
FOFAFamily Office of America Inc.
$0.75+0.00%16

Spot a number that looks wrong? Check it in GUTS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing GUTS

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.